Buy Givlaari (givosiran) online

Description

Buy Givlaari (givosiran) online

Givlaari (givosiran) is a medication used for the treatment of adult patients and children aged 12 years and older with acute hepatic porphyria.

Buy Givlaari (givosiran) online

What is Givlaari (givosiran) for?
Givlaari (givosiran) is an aminolevulinate synthase 1-directed small interfering RNA (siRNA) indicated for the treatment of adults and children aged 12 years and older with acute hepatic porphyria (AHP). [1,4]

It is available in single-dose vial form containing 189 mg/ml givosiran.[1]

How does Givlaari (givosiran) work?
AHP is a rare genetic disorder in which one of the enzymes in the heme pathway is not functioning properly. Heme plays an important role in the body, because it helps bind and transport oxygen in the blood. The heme pathway is controlled in the liver by the enzyme aminolevulinate synthase 1 (ALAS1).[2]

Certain triggers can cause ALAS1 levels to increase, and this in turn causes the buildup of neurotoxic molecules called aminolevulinic acid (ALA) and porphobilinogen (PBG). ALA and PBG cause harm to nerve cells, and thereby cause the symptoms and (potentially life-threatening) attacks of AHP.[2] Givosiran is a double-stranded small interfering RNA that reduces levels of ALA and PBG. This helps protect patients against attacks and other symptoms of AHP.[1,2]

Buy Givlaari (givosiran) online

Where has Givlaari (givosiran) been approved?
Givlaari (givosiran) was approved by:

The Food and Drug Administration (FDA), USA, on November 20, 2019 for the treatment of adult patients with AHP.[3]
The European Medicines Agency (EMA), on January 31, 2020 for the treatment of adults and children aged 12 years and older with AHP.[4]
The FDA granted Givlaari (givosiran) Priority Review and Breakthrough Therapy designation. Givlaari also received Orphan Drug designation by the FDA and EMA, which is intended to encourage the development of treatments for rare diseases.[3]

Please note that this medicine may have also been approved in other regions than the ones we’ve listed. If you have a question about its approval in a specific country feel free to contact our support team.

How is Givlaari (givosiran) taken?
The standard dosage is:[1]

Buy Givlaari (givosiran) online

2.5 mg/kg actual body weight administered via subcutaneous injection once per month.
In case of a missed dose, Givlaari (givosiran) should be administered as soon as possible. Resume monthly dosing starting thereafter.[1]

If transaminase levels are significantly increased, dosage should be reduced to 1.25 mg/kg once monthly. When after dose reduction, transaminase levels are not significantly increased, the standard dose of 2.5 mg/kg once monthly may be resumed.[1]

Complete information about Givlaari (givosiran) dosage and administration can be found in the official prescribing information listed in our references section.[1]

Note: Please consult with your treating doctor for personalised dosing.

Are there any known adverse reactions or side effects of Givlaari?
Common adverse reactions
The most common adverse reactions (≥20% of patients) listed in the prescribing information include:[1]

Nausea
Injection site reactions
Serious adverse reactions
The serious adverse reactions listed in the prescribing information include:[1]

Buy Givlaari (givosiran) online

Severe allergic reactions (anaphylactic reactions)
Liver problems
Kidney problems
Injection site reactions
Use in a specific population
Givlaari (givosiran) can cause fetal harm when administered to a pregnant woman; it is advised to avoid pregnancies and breastfeeding.[1]

For a comprehensive list of side effects and adverse reactions please refer to the official prescribing information.[1]

References
1. Full prescribing information [FDA]: Givlaari (givosiran) [PDF]
Alnylam Pharmaceuticals, Nov 20, 2019

2. Understanding Acute Hepatic Porphyria
Alnylam Pharmaceuticals, last checked on Aug 19, 2020

3. FDA approves first treatment for inherited rare disease
FDA press release, Nov 20, 2019

4. First treatment for acute hepatic porphyria Share
Givlaari (Givosiran)

What is Givlaari used for?

Givlaari for acute hepatic porphyria

Givlaari injection

Givlaari 2.5 mg/ml

Givlaari treatment for porphyria

Givlaari cost

Buy Givlaari online

Givlaari dosage instructions

Givlaari side effects

Usage and Effectiveness:
Givlaari for treating acute hepatic porphyria

Givlaari for AHP treatment

How does Givlaari work for porphyria?

Givlaari for managing acute porphyria attacks

Givlaari and porphyria symptoms

How effective is Givlaari for AHP?

Givlaari for reducing porphyria attacks

Givlaari for preventing AHP symptoms

Givlaari treatment plan for porphyria

Givlaari vs other treatments for AHP

Side Effects and Safety:
Givlaari side effects

Common side effects of Givlaari

Serious side effects of Givlaari

Givlaari injection site reactions

Givlaari and liver issues

Givlaari and nausea

Givlaari and headache

Givlaari and muscle pain

Givlaari and kidney function

Givlaari and fatigue

Dosage and Administration:
Givlaari dosage for acute hepatic porphyria

How to administer Givlaari injection

Givlaari 2.5 mg/ml injection schedule

Givlaari dosage for preventing porphyria attacks

How often do you take Givlaari?

Givlaari injection frequency

Givlaari treatment protocol

Givlaari for acute porphyria attack prevention

Givlaari dosing for AHP patients

How to inject Givlaari for AHP

Cost and Insurance:
Givlaari cost

How much does Givlaari cost?

Givlaari price without insurance

Givlaari financial assistance program

Givlaari price per dose

Givlaari insurance coverage

Givlaari co-pay assistance

Givlaari cost per month

Givlaari discount programs

Buy Givlaari at a discount

Comparisons with Other Treatments:
Givlaari vs Panhematin (heme arginate)

Givlaari vs heme therapy for AHP

Givlaari vs other treatments for acute hepatic porphyria

Givlaari vs intravenous heme therapy

Givlaari vs liver transplant for porphyria

Givlaari vs hematin for AHP treatment

Givlaari vs acute porphyria attack prevention drugs

Givlaari vs other AHP medications

Givlaari vs intravenous glucose for AHP

Givlaari vs alternative treatments for porphyria

Patient Experiences and Testimonials:
Givlaari patient reviews

Does Givlaari work for AHP?

Givlaari side effects patient feedback

Givlaari success stories

Givlaari treatment results

Givlaari for preventing AHP attacks

Givlaari for reducing symptoms of acute porphyria

Does Givlaari cause weight gain?

Givlaari and quality of life for AHP patients

Givlaari patient stories for porphyria treatment

Precautions and Warnings:
Givlaari precautions

Who should not take Givlaari?

Givlaari and pregnancy

Givlaari and liver problems

Givlaari and kidney disease

Givlaari and other drug interactions

Givlaari warnings for AHP patients

Givlaari and blood disorders

Givlaari contraindications

Givlaari and risk of infections

Buy Givlaari (givosiran) online